Logo image of COUR

COURSERA INC (COUR) Stock Fundamental Analysis

USA - NYSE:COUR - US22266M1045 - Common Stock

11.59 USD
+0.27 (+2.39%)
Last: 9/18/2025, 8:04:00 PM
11.8 USD
+0.21 (+1.81%)
After Hours: 9/18/2025, 8:04:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to COUR. COUR was compared to 74 industry peers in the Diversified Consumer Services industry. COUR has a great financial health rating, but its profitability evaluates not so good. COUR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

COUR had positive earnings in the past year.
COUR had a positive operating cash flow in the past year.
COUR had negative earnings in each of the past 5 years.
In multiple years COUR reported negative operating cash flow during the last 5 years.
COUR Yearly Net Income VS EBIT VS OCF VS FCFCOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

COUR's Return On Assets of -5.19% is in line compared to the rest of the industry. COUR outperforms 41.89% of its industry peers.
COUR's Return On Equity of -8.12% is in line compared to the rest of the industry. COUR outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA -5.19%
ROE -8.12%
ROIC N/A
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
COUR Yearly ROA, ROE, ROICCOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

Looking at the Gross Margin, with a value of 54.37%, COUR is in the better half of the industry, outperforming 64.86% of the companies in the same industry.
COUR's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for COUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
COUR Yearly Profit, Operating, Gross MarginsCOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for COUR has been increased compared to 1 year ago.
The number of shares outstanding for COUR has been increased compared to 5 years ago.
There is no outstanding debt for COUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
COUR Yearly Shares OutstandingCOUR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
COUR Yearly Total Debt VS Total AssetsCOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 3.04 indicates that COUR is not in any danger for bankruptcy at the moment.
The Altman-Z score of COUR (3.04) is better than 71.62% of its industry peers.
There is no outstanding debt for COUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.04
ROIC/WACCN/A
WACC8.7%
COUR Yearly LT Debt VS Equity VS FCFCOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

COUR has a Current Ratio of 2.55. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of COUR (2.55) is better than 79.73% of its industry peers.
A Quick Ratio of 2.55 indicates that COUR has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.55, COUR is doing good in the industry, outperforming 79.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.55
Quick Ratio 2.55
COUR Yearly Current Assets VS Current LiabilitesCOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

5

3. Growth

3.1 Past

COUR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.00%, which is quite impressive.
The Revenue has been growing slightly by 7.11% in the past year.
Measured over the past years, COUR shows a very strong growth in Revenue. The Revenue has been growing by 30.38% on average per year.
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)7.11%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%9.84%

3.2 Future

The Earnings Per Share is expected to grow by 18.64% on average over the next years. This is quite good.
COUR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.79% yearly.
EPS Next Y15.5%
EPS Next 2Y15.91%
EPS Next 3Y18.64%
EPS Next 5YN/A
Revenue Next Year7.58%
Revenue Next 2Y6.6%
Revenue Next 3Y6.79%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COUR Yearly Revenue VS EstimatesCOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
COUR Yearly EPS VS EstimatesCOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.60, the valuation of COUR can be described as expensive.
60.81% of the companies in the same industry are more expensive than COUR, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of COUR to the average of the S&P500 Index (27.41), we can say COUR is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 25.37, the valuation of COUR can be described as expensive.
Based on the Price/Forward Earnings ratio, COUR is valued a bit cheaper than 60.81% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.88, COUR is valued at the same level.
Industry RankSector Rank
PE 27.6
Fwd PE 25.37
COUR Price Earnings VS Forward Price EarningsCOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of COUR indicates a somewhat cheap valuation: COUR is cheaper than 67.57% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 24.32
EV/EBITDA N/A
COUR Per share dataCOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as COUR's earnings are expected to grow with 18.64% in the coming years.
PEG (NY)1.78
PEG (5Y)N/A
EPS Next 2Y15.91%
EPS Next 3Y18.64%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for COUR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COURSERA INC

NYSE:COUR (9/18/2025, 8:04:00 PM)

After market: 11.8 +0.21 (+1.81%)

11.59

+0.27 (+2.39%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners79.9%
Inst Owner Change0.28%
Ins Owners6.59%
Ins Owner Change0.88%
Market Cap1.90B
Analysts74.29
Price Target12.5 (7.85%)
Short Float %4.21%
Short Ratio1.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.93%
Min EPS beat(2)36.12%
Max EPS beat(2)49.74%
EPS beat(4)4
Avg EPS beat(4)133.56%
Min EPS beat(4)36.12%
Max EPS beat(4)356%
EPS beat(8)8
Avg EPS beat(8)1329.89%
EPS beat(12)12
Avg EPS beat(12)910.27%
EPS beat(16)14
Avg EPS beat(16)685.05%
Revenue beat(2)2
Avg Revenue beat(2)0.91%
Min Revenue beat(2)0.22%
Max Revenue beat(2)1.6%
Revenue beat(4)2
Avg Revenue beat(4)0.14%
Min Revenue beat(4)-0.77%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.31%
Revenue beat(12)9
Avg Revenue beat(12)1.29%
Revenue beat(16)11
Avg Revenue beat(16)0.69%
PT rev (1m)0%
PT rev (3m)25.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.53%
EPS NY rev (1m)10%
EPS NY rev (3m)10.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.96%
Revenue NY rev (1m)0.32%
Revenue NY rev (3m)2.44%
Valuation
Industry RankSector Rank
PE 27.6
Fwd PE 25.37
P/S 2.63
P/FCF 24.32
P/OCF 16.35
P/B 3.03
P/tB 3.16
EV/EBITDA N/A
EPS(TTM)0.42
EY3.62%
EPS(NY)0.46
Fwd EY3.94%
FCF(TTM)0.48
FCFY4.11%
OCF(TTM)0.71
OCFY6.12%
SpS4.41
BVpS3.83
TBVpS3.67
PEG (NY)1.78
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.19%
ROE -8.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.37%
FCFM 10.81%
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 141.09%
Cap/Sales 5.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.55
Quick Ratio 2.55
Altman-Z 3.04
F-Score5
WACC8.7%
ROIC/WACCN/A
Cap/Depr(3y)108%
Cap/Depr(5y)109.75%
Cap/Sales(3y)3.84%
Cap/Sales(5y)3.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y15.5%
EPS Next 2Y15.91%
EPS Next 3Y18.64%
EPS Next 5YN/A
Revenue 1Y (TTM)7.11%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%9.84%
Revenue Next Year7.58%
Revenue Next 2Y6.6%
Revenue Next 3Y6.79%
Revenue Next 5YN/A
EBIT growth 1Y39.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year256.3%
EBIT Next 3Y79.6%
EBIT Next 5YN/A
FCF growth 1Y527.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5081.12%
OCF growth 3Y279.12%
OCF growth 5YN/A